Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_assertion description "[Poly(ADP-ribose) polymerase inhibitors (PARPi) are currently evaluated in clinical trials in combination with topoisomerase I (Top1) inhibitors against a variety of cancers, including colon carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_assertion evidence source_evidence_literature NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_assertion SIO_000772 23653048 NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_assertion wasDerivedFrom befree-20150227 NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_assertion wasGeneratedBy ECO_0000203 NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP748930.RALO3lmE1T1lbCP9zp7zpoy7KV-Z6Cy-MkNdeU383YAI0130_provenance.